Copyright
        ©The Author(s) 2019.
    
    
        World J Gastrointest Pathophysiol. Dec 31, 2019; 10(5): 54-63
Published online Dec 31, 2019. doi: 10.4291/wjgp.v10.i5.54
Published online Dec 31, 2019. doi: 10.4291/wjgp.v10.i5.54
            Table 1 Patient characteristics, n (%)
        
    | Characteristics | UC (n = 57) | CD (n = 131) | |
| Gender | Female | 27 (47) | 83 (63) | 
| Male | 30 (53) | 48 (37) | |
| Disease duration (yr) | 0-5 | 37 (65) | 72 (55) | 
| 6 to 10 | 9 (16) | 16 (12) | |
| > 10 | 11 (19) | 43 (33) | |
| Smoking | Current | 1 (2) | 32 (25) | 
| Former | 29 (51) | 37 (28) | |
| Never | 27 (47) | 62 (47) | |
| Biomarkers | Lactoferrin μg/g | 448 (0; 8467) | 95 (0; 9351) | 
| Median (min; max) | CRP mg/dL | 0.54 (0.4; 17.3) | 1.15 (0.4; 21.1) | 
| WBC (K/μL) | 8.2 (4.0; 29.9) | 7.5 (3.6; 26.4) | |
| Montreal age (yr) | A1 < 16 | 0 (0) | 4 (3) | 
| A2 17-40 | 29 (51) | 47 (36) | |
| A3 > 40 | 28 (49) | 80 (61) | |
| Montreal class UC | E1 proctitis | 4 (7) | |
| E2 distal | 17 (30) | ||
| E3 extensive | 36 (63) | ||
| Disease activity by DAI | Mild (1) | 11 (19) | |
| Moderate (2) | 27 (48) | ||
| Severe (3) | 19 (33) | ||
| Montreal class CD | L1 ileal | 45 (34) | |
| L2 colonic | 57 (44) | ||
| L3 ileocolonic | 29 (22) | ||
| L4 isolated upper | 0 (0) | ||
| B1 nonstricturing | 95 (73) | ||
| B2 stricturing | 24 (18) | ||
| B3 penetrating | 12 (9) | ||
| P perianal | 4 (3) | ||
| Disease activity by SES-CD | Inactive (0-2) | 9 (10) | |
| Mild (3-6) | 20 (22) | ||
| Moderate (7-15) | 26 (28) | ||
| Severe (≥ 16) | 37 (40) | 
            Table 2 Correlation of Simple Endoscopic Score for Crohn’s disease and Disease Activity Index and biomarkers
        
    
            Table 3 Spearman correlation of fecal lactoferrin with Simple Endoscopic Score for Crohn’s disease and Disease Activity Index according to timing of tests
        
    
            Table 4 Median fecal lactoferrin vs extent of colonic disease
        
    | Number of inflamed colon segments | Number of patients | Median FL (µg/g) | 
| 0-1 | 37 | 8 | 
| 2-3 | 42 | 91.5 | 
| 4-5 | 21 | 302 | 
| 6-7 | 43 | 789 | 
- Citation: Rubio MG, Amo-Mensah K, Gray JM, Nguyen VQ, Nakat S, Grider D, Love K, Boone JH, Sorrentino D. Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease. World J Gastrointest Pathophysiol 2019; 10(5): 54-63
- URL: https://www.wjgnet.com/2150-5330/full/v10/i5/54.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v10.i5.54

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        